ALB and cerebral infarction: In the first part of this study, we demonstrated that both BSA and HSA in aCSF buffer, used in tMD therapy, significantly reduced the volume of cerebral infarction, promoted cell survival, and substantially improved behavioral function in animals with ischemic stroke.